Ownership and Use of Data. The Pseudonymized Personal Data and Study Results shall be the sole property of the SPONSOR and shall be subject to the SPONSOR's exclusive use, commercial or otherwise, including use (directly or via third parties) in publications, communications or in submissions to any regulatory authority or other governmental agency. Subject to the confidentiality provisions of this Agreement, the SPONSOR hereby grants to the INSTITUTION and/or the INVESTIGATOR a non-exclusive, non-transferable and non-assignable right to use the Pseudonymized Personal Data and Study Results solely for non-commercial research purposes, educational purposes, patient care purposes and, subject to Article 6.3, for publication purposes.
Ownership and Use of Data. (1) Xxxxxxxx agrees and acknowledges that Parent owns all data, compilation, collective and similar rights, title and interests worldwide in the OrderBox Database, and all information and derivative works generated from the OrderBox Database.
(2) Parent and Service Providers and their designees/agents have the right to backup, copy, publish, disclose, use, sell, modify, process this data in any form and manner as maybe required for compliance of any agreements executed by Parent or Service Providers, or in order to fulfill services under this Agreement, or for any other appropriate reason.
Ownership and Use of Data. All data created from information, documents, messages (verbal or electronic), Reports, or meetings involving or arising out of this Contract is owned by DCH, hereafter referred to as DCH Data. The Contractor shall make all data available to DCH, who will also provide it to CMS upon request. The Contractor is expressly prohibited from sharing or publishing DCH Data or any information relating to Medicaid data without the prior written consent of DCH. In the event of a dispute regarding what is or is not DCH Data, DCH’s decision on this matter shall be final and not subject to Appeal.
Ownership and Use of Data. The Study Data shall be the sole property of the SPONSOR and shall be subject to the SPONSOR's exclusive use, commercial or otherwise, including use in publications, communications or in submissions to any regulatory authority or other governmental agency. Subject to the confidentiality provisions of this Agreement, the SPONSOR hereby grants to the INSTITUTION and/or the INVESTIGATOR a non-exclusive, non-transferable and non-assignable right to use the Study Data solely for non-commercial research purposes, educational purposes and, subject to Article 6.3, for publication purposes.
Ownership and Use of Data. To the extent permissible and in compliance with Payment Network Rules, applicable law, and as between the Parties, Xxxxxxxxx.Xxx shall retain full ownership of all data submitted by Company and/or Merchant in connection with Merchant’s enrollment for and use of the Xxxxxxxxx.Xxx Services and hosted or stored on Xxxxxxxxx.Xxx servers, including but not limited to: name, mailing and shipping address, email address, phone number, dollar amount of purchase, type of purchase and description of purchase. Xxxxxxxxx.Xxx agrees to use such data only as necessary to perform hereunder and for no other purpose, and hereby grants Company a royalty-free, fully paid up right, during the Term, to use such data only as necessary to perform its rights and obligations hereunder and for no other purpose. Nothing in this Agreement shall prevent or restrict Company from using any information it collects or receives independent of its performance under this Agreement.
Ownership and Use of Data. (1) You agree and acknowledge that Registrar owns all data, compilation, collective and similar rights, title and interests worldwide in the OrderBox Database, and all information and derivative works generated from the OrderBox Database.
(2) Registrar, Service Providers and the Registry Operator and their designees/agents have the right to backup, copy, publish, disclose, use, sell, modify, process this data in any form and manner as maybe required for compliance of any agreements executed by Registrar, or Registry Operator or Service Providers, or in order to fulfill services under this Agreement, or for any other appropriate reason.
Ownership and Use of Data. 4.6.1 Each Party shall own all data, results, information, developments and documentation generated by activities that were funded solely by it prior to the Date of Agreement.
4.6.2 USL shall own all data, results, information, developments and documentation generated by activities undertaken after the Date of Agreement in connection with or pursuant to the Development Plan, or otherwise undertaken or paid for by USL, provided that USL and Orion shall jointly own all data, results, information, developments and documentation generated by activities after the Date of Agreement to the extent Orion joins USL in funding such activities, and Orion’s funding exceeds the [***] amount specified in Section 4.7(a)(1). Manufacturing process development and validation, manufacturing scale-up, stability testing, or quality assurance/quality control development for the Product shall be performed by Orion, at its expense, and data, information and documentation related thereto (which is not to be reimbursed by USL) shall be Orion’s Proprietary Information owned by Orion, and USL shall have the right to use all such Orion Proprietary Information as provided in this Agreement.
4.6.3 It is understood that the terms of Sections 4.6.1 and 4.6.2 shall apply regardless of whether the activity was conducted directly by a Party or by a Third Party (e.g., a contract research organization) on behalf of such Party. Data, results, information, developments and documentation owned by USL in accordance with this Section 4.6 is referred to as “USL Data” and shall be proprietary and confidential to USL. Orion assigns to USL any right it may have in USL Data, and agrees to execute any documents as USL may reasonably request to document and confirm USL’s ownership of the USL Data.
(a) Orion shall make available all data, results, information, development and documentation of Orion that is a part of Orion Proprietary Information for use in connection with USL’s performance of this Agreement regarding the Product in the Territory. USL agrees to share with Orion all pre-clinical and clinical research data and results involving Product which it has developed, develops, or obtains from a Third Party during the Term, as well as correspondence with the FDA and minutes of meetings with the FDA regarding the Product. Such sharing by each Party shall take place as soon as reasonably practicable after such data or results become available, but in no event shall a final study report (“Final Study Repo...
Ownership and Use of Data. The Recipient is the custodian of the Data. Data Provider grants the Recipient a non-exclusive licence to use the Data solely for the Research Programme. Except as provided for in clause 2.3, the Recipient shall not use the Data without the prior written consent of Data Provider for any commercial purpose even if such purposes are being pursued in the Recipient Scientist’s laboratory. The Recipient agrees not to make intellectual property claims on the Data and not to use IP protection in ways that would prevent or block access to, or use of, any element of the Data, but may use Data for future research.
Ownership and Use of Data. All data created from information, documents, messages (verbal or electronic), reports, or meetings involving or arising out of this Contract is owned by DCH, hereafter referred to as DCH Data. The Contractor shall make all data available to DCH, who will also provide it to CMS upon request. The Contractor is expressly prohibited from sharing or publishing DCH Data or any information relating to Medicaid data without the prior written consent of DCH. In the event of a dispute regarding what is or is not DCH Data, DCH’s decision on this matter shall be final and not subject to Appeal. If DCH consents to the publication of its data by Contractor, Contractor shall display the following statement within the publication in a clear and conspicuous manner: The statement shall not be considered clear and conspicuous if it is difficult to read or hear, or if the placement is easily overlooked. The Contractor warrants that all deliverables provided by the Contractor do not and will not infringe or misappropriate any right of any third party based on copyright, patent, trade secret, or other intellectual property rights. In case the deliverables or any one or part thereof is held or alleged to constitute an infringement or misappropriation, or the use thereof is enjoined or restricted or if a proceeding appears to the Contractor to be likely to be brought, the Contractor will, at its own expense, either: § Procure for the Department the right to continue using the deliverables; or, § Modify or replace the deliverables to comply with the specifications so that no violation of any intellectual property right occurs. If Contractor fails to comply with the terms and conditions set forth in this section, DCH shall have the option to terminate the Contract.
Ownership and Use of Data. Subject to Applicable Laws, Dyax shall have the following rights with respect to information and data relating to Product, the sale of Product to Specialty Pharmacy Customers and the use by Product of Patients obtained, maintained, generated or furnished by US Bio to Dyax in connection with performing US Bio’s obligations hereunder, including such data and information contained in the reports delivered pursuant to Sections 10.1 and 10.2:
(a) With respect to the activity and other data generated in connection with the Hub Services (which shall be captured in the Hub Services database and may be reported to Dyax pursuant to this Agreement), Dyax shall own and have the exclusive right to use all such information and data (provided, that US Bio may use any and all information and data to the extent required in its performance of the Hub Services or as otherwise necessary in connection with its dispensing of Product and related services to Patients) and all such information shall be deemed to be Dyax Confidential Information; and
(b) The parties acknowledge and agree that US Bio shall own product dispensing data and any other clinical data related to such dispensing activities. With respect to all information and data not covered by Section 10.4(a) but which is provided by US Bio to Dyax in accordance with this Agreement, Dyax shall have a right to use any and all information and data, for any purpose as permitted by law or, to the extent such data contain PHI, as permitted by the applicable patient’s written authorization or as otherwise allowed under the law.
